Vaccine News and Research

Latest Vaccine News and Research

Is COVID-19 vaccination in California equitable yet?

Is COVID-19 vaccination in California equitable yet?

NIH launches first-in-human, Phase 1 trial assessing investigational nanoparticle influenza vaccine

NIH launches first-in-human, Phase 1 trial assessing investigational nanoparticle influenza vaccine

Study confirms poor immunogenicity in hemodialysis patients receiving single dose BNT162b2 vaccine

Study confirms poor immunogenicity in hemodialysis patients receiving single dose BNT162b2 vaccine

Scientists explain possible causes of anaphylaxis following mRNA COVID-19 vaccination

Scientists explain possible causes of anaphylaxis following mRNA COVID-19 vaccination

NIH starts Phase 1/2 clinical trial evaluating mixed COVID-19 vaccine schedules

NIH starts Phase 1/2 clinical trial evaluating mixed COVID-19 vaccine schedules

Scientists use an original approach to resolve the 3D structure of flaviviruses

Scientists use an original approach to resolve the 3D structure of flaviviruses

Antibody cocktail effectively inhibits SARS-CoV-2 in the rhesus macaque model

Antibody cocktail effectively inhibits SARS-CoV-2 in the rhesus macaque model

Researchers identify common epitopes across SARS-CoV-2 viral variants

Researchers identify common epitopes across SARS-CoV-2 viral variants

Using Sotrovimab to treat COVID-19 early

Using Sotrovimab to treat COVID-19 early

Report on the effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in Canada

Report on the effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in Canada

SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds

SARS-CoV-2 variants partially escape humoral immunity, but not T cells responses, study finds

A novel multi-epitope COVID-19 vaccine developed using reverse vaccinology

A novel multi-epitope COVID-19 vaccine developed using reverse vaccinology

Researchers identify defensins as potential anti-SARS-CoV-2 agents

Researchers identify defensins as potential anti-SARS-CoV-2 agents

A call to action to share 2 billion doses of COVAX in 2021

A call to action to share 2 billion doses of COVAX in 2021

Researchers review 50 years of progress in women's health

Researchers review 50 years of progress in women's health

B.1.617.2 variant of SARS-CoV-2 is partially resistant to antibody-mediated neutralization

B.1.617.2 variant of SARS-CoV-2 is partially resistant to antibody-mediated neutralization

Reusing old vaccines to boost innate immunity against COVID-19

Reusing old vaccines to boost innate immunity against COVID-19

Chemists use new technique to manufacture pharmaceutical cholesterol from plant-based materials

Chemists use new technique to manufacture pharmaceutical cholesterol from plant-based materials

Synbal and La Jolla Institute for Immunology collaborate to develop better COVID-19 models

Synbal and La Jolla Institute for Immunology collaborate to develop better COVID-19 models

Composition and function of gut microbiota are key in affecting immune responses to vaccinations

Composition and function of gut microbiota are key in affecting immune responses to vaccinations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.